EUVIMEDEUVIMED entdecken
Crossref

Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression

Zhang Fan, Han Shuai

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Zhang Fan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Thera…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Glucosides, Lung Neoplasms, Lipid Metabolism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Polydatin (PD) is a glucan extracted from the plant Polygonum cuspidatum that possesses a wide range of pharmacological activities. However, the mechanism underlying its the influence of PD on NSCLC is not clear. OBJECTIVE: To explore the mechanism of action of PD against non-small cell lung cancer (NSCLC) using a combination of bioinformatics and experimental validation. METHODS: We utilized bioinformatics methods with the TCGA, ferroptosis, and lipid metabolism databases to assess the value, distribution, and potential role linkages of the core targets in NSCLC therapy. In vivo experiments were conducted using in situ tumor mouse models to confirm the inhibitory effect of PD on NSCLC. RESULTS: Network pharmacology analysis revealed that 76 PD-related genes associated with NSCLC and five hub targets, including EGFR, TNF, ALB, CASP3, ERBB2, lipids and atherosclerosis, and the TNF signaling pathway might play essential roles in the anti-NSCLC effect of PD. EGFR and TNF are potential driver genes for ferroptosis. LASSO regression analysis was used to screen potential genes and construct an independent prognostic model of 26 LMRGs. Six genes (PLIN1, ALPI, DECR1, GPAM, OSBPL5, and MED19) were further identified by multivariate Cox regression analysis. The construction of risk models associated with LMRGs has strong potential for the prognostic prediction of NSCCLC patients. Cell and animal experiments also confirmed that PD inhibits LLC cell invasion and propagation ability. CONCLUSION: This study revealed that PD may regulate multiple signaling pathways by targeting genes such as EGFR, TNF, and LMRGS to inhibit NSCLC proliferation and metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungGlucosidesLung NeoplasmsLipid MetabolismStilbenesNetwork PharmacologyGene Expression Regulation, NeoplasticAnimalsHumansMicePrognosisCell Line, TumorXenograft Model Antitumor AssaysComputational BiologyFerroptosisA549 CellsCell Proliferation

Stichwörter der Autor:innen

Animal modelLipid metabolismNSCLCNetwork pharmacologyPolydatinPrognosis

Substanzen

polydatinGlucosidesStilbenes

Autor:innen und Institutionen

  • Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China. Electronic address: zhangfan89@163.com.
  • Experimental Animal Center of Inner Mongolia Medical University, Inner Mongolia Medical University, Inner Mongolia, Hohhot 010050, China.

Zitieren

APA

Fan, Z., & Shuai, H. (2024). Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113172

Vancouver

Fan Z, Shuai H. Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113172

BibTeX
@article{Fan2024,
  author = {Fan, Zhang and Shuai, Han},
  title = {Strategies for exploring mechanisms of polydatin against NSCLC based on experimentally validated network pharmacology and prognostic prediction of lipid metabolism gene expression},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113172}
}
Kostenlos starten →